Výsledky vyhledávání - "Caroline Kerner"

REAL-WORLD USTEKINUMAB PERSISTENCE IN PATIENTS WITH ULCERATIVE COLITIS ATTAINING THE MAINTENANCE PHASE

Autor: Maryia Zhdanava, Sumesh Kachroo, Aditi Shah, Zhijie Ding, Christopher Holiday, Patrick Lefebvre, Ruizhi Zhao, Caroline Kerner, Dominic Pilon

Publikováno v: Gastroenterology. 164:S46-S47

BACKGROUND Sustained use of biologics and small molecule/advanced therapy has proven to be effective for controlling disease activity in ulcerative colitis (UC). The anti-interleukin agent ustekinumab was recently approved for UC in 2019. This study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a3f79c689bd320c09c79dd57da6473d
https://doi.org/10.1053/j.gastro.2023.03.086

Zobrazit plný text záznamu

Impact of JC Virus Antibody Testing in Patients with Crohnʼs Disease with Loss of Response to Infliximab

Autor: Frank I. Scott, James D. Lewis, Monica Lorusso, Mark T. Osterman, Ryan A. McConnell, Faten Aberra, Gary R. Lichtenstein, Caroline Kerner

Publikováno v: Inflammatory Bowel Diseases. 19:2625-2633

Background The optimal treatment strategy for patients with Crohn's disease who have loss of response to the anti-tumor necrosis factor α medication infliximab is uncertain. Natalizumab has an alternative mechanism of action, but its use has been li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2970e995c4089edd49e27d3e3da22a
https://doi.org/10.1097/01.mib.0000437043.36338.21

Zobrazit plný text záznamu

Clinical Predictors of Urgent Findings on Abdominopelvic CT in Emergency Department Patients with Crohn’s Disease

Autor: Wei Yang, Charles Baillie, Kathleen Carey, Angela M. Mills, Mark G. Weiner, James D. Lewis, Susan Hilton, Caroline Kerner, Marie Synnestvedt

Publikováno v: Inflammatory Bowel Diseases. 19:1179-1185

BACKGROUND Patients with Crohn's disease (CD) are frequently exposed to diagnostic radiation in emergency departments (EDs). We aimed to examine clinical predictors of urgent abdominopelvic computed tomography (APCT) findings in this population. METH

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8dd9a8d7d75b5a6f65e8f8dd559d5073
https://doi.org/10.1097/mib.0b013e31828133ad

Zobrazit plný text záznamu

Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients

Autor: Amy Praestgaard, Kimberly A. Forde, Rotonya M. Carr, Gary R. Lichtenstein, Hillary Bownik, Arpan Patel, Amanke Oranu, Caroline Kerner, K. Rajender Reddy

Publikováno v: Digestive diseases and sciences. 62(5)

Nonalcoholic fatty liver disease (NAFLD) is a common cause of hepatic steatosis in patients with inflammatory bowel disease (IBD). Both metabolic syndrome (MetS) and intestinal inflammation are implicated in NAFLD pathogenesis. We performed a retrosp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f4349646a1e3476a77389f8d7cc0dbb
https://pubmed.ncbi.nlm.nih.gov/28676901

Zobrazit plný text záznamu

Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse

Autor: F. Reed Johnson, James D. Lewis, Erin Gilroy, Angelyn O. Fairchild, Meenakshi Bewtra, David A. Leiman, Caroline Kerner

Publikováno v: The American journal of gastroenterology. 110(12)

Biomarkers, endoscopy and imaging tests can identify patients at increased risk for early recurrence of symptomatic inflammatory bowel disease (IBD). However, patients may be unwilling to accept additional medical therapy risks related to therapy esc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e38668772156065aa5536a668cd5bd9
https://pubmed.ncbi.nlm.nih.gov/26482859

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání